BANK VONTOBEL/CALL/PFIZER INC/29/0.1/17.01.25 Share Price

Warrant

DE000VM9BX72

Real-time Boerse Frankfurt Warrants 09:12:04 04/07/2024 BST
0.147 EUR +6.52% Intraday chart for BANK VONTOBEL/CALL/PFIZER INC/29/0.1/17.01.25
Current month-11.54%
1 month-42.50%
Date Price Change
04/07/24 0.147 +6.52%
03/07/24 0.138 -6.12%
02/07/24 0.147 -10.91%
01/07/24 0.165 +5.77%
28/06/24 0.156 +6.12%

Real-time Boerse Frankfurt Warrants

Last update July 04, 2024 at 09:12 am

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying PFIZER, INC.
IssuerLogo Issuer Vontobel Vontobel
WKN VM9BX7
ISINDE000VM9BX72
Date issued 30/01/2024
Strike 29 $
Maturity 17/01/2025 (198 Days)
Parity 10 : 1
Emission price 0.21
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.27
Lowest since issue 0.1
Delta0.44x
Omega 7.401
Premium10.62x
Gearing16.88x
Moneyness 0.9552
Difference Strike 1.3 $
Difference Strike %+4.48%
Spread 0.01
Spread %6.37%
Theoretical value 0.1530
Implied Volatility 27.60 %
Total Loss Probability 62.98 %
Intrinsic value 0.000000
Present value 0.1530
Break even 30.65 €
Theta-0x
Vega0.01x
Rho0x

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
27.7 USD
Average target price
31.92 USD
Spread / Average Target
+15.22%
Consensus